Biogen reports Litifilimab safety profile consistent
Biogen Inc. announced that the safety profile of Litifilimab has been observed to be consistent, with no new safety signals identified.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.